Showing results (911-920 of 991) with videos related to

Sort By:
Pageof 100
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2023
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trialJ Ferdinandus, H Müller, C Damaschin, et al.
British Journal of Haematology|August 28, 2015
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study GroupPaul J Bröckelmann, Helen Goergen, Michael Fuchs, et al.
JAMA Oncology|May 1, 2020
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL TrialPaul J Bröckelmann, Helen Goergen, Ulrich Keller, et al.
Blood|September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphomaCarsten Kobe, Markus Dietlein, Jeremy Franklin, et al.
Cancer Immunology Research|April 24, 2020
Tumor Fusion Burden as a Hallmark of Immune Infiltration in Prostate CancerMarie-Claire Wagle, Joseph Castillo, Shrividhya Srinivasan, et al.
British Journal of Cancer|December 30, 2023
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancerAnaís Sánchez-Castillo, Elien Heylen, Judith Hounjet, et al.
Insects|March 28, 2026
The Ifakara Ambient Chamber Test (I-ACT) for Evaluation of Indoor Residual Sprays: A Non-Inferiority Test of Sylando<sup>®</sup> 240SC and SumiShield<sup>®</sup> 50WGJane Johnson Machange, Ahmadi B Mpelepele, Frank S C Tenywa, et al.
Nature Medicine|January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialThomas Powles, Kobe C Yuen, Silke Gillessen, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 25, 2012
Conserved anchorless surface proteins as group A streptococcal vaccine candidatesAnna Henningham, Emiliano Chiarot, Christine M Gillen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.
Pageof 100